Package 69097-829-05
Brand: quinapril and hydrochlorothiazide 20/12.5
Generic: quinapril and hydrochlorothiazide 20/12.5Package Facts
Identity
Package NDC
69097-829-05
Digits Only
6909782905
Product NDC
69097-829
Description
90 TABLET in 1 BOTTLE (69097-829-05)
Marketing
Marketing Status
Brand
quinapril and hydrochlorothiazide 20/12.5
Generic
quinapril and hydrochlorothiazide 20/12.5
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4d3f7e7a-ed61-4df6-bc45-f38fb4117406", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0369097831059", "0369097829056"], "unii": ["0J48LPH2TH", "33067B3N2M"], "rxcui": ["310796", "310797", "310809"], "spl_set_id": ["1de5420c-23d6-40c5-ba24-39143c0f90fb"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (69097-829-05)", "package_ndc": "69097-829-05", "marketing_start_date": "20160720"}], "brand_name": "Quinapril and Hydrochlorothiazide 20/12.5", "product_id": "69097-829_4d3f7e7a-ed61-4df6-bc45-f38fb4117406", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "69097-829", "generic_name": "Quinapril and Hydrochlorothiazide 20/12.5", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Quinapril and Hydrochlorothiazide 20/12.5", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "QUINAPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA201356", "marketing_category": "ANDA", "marketing_start_date": "20160720", "listing_expiration_date": "20261231"}